Workshop co-organized by IABS and FDA

Scientific Committee

Arifa S. Khan
William Egan
GlaxoSmithKline Vaccines, USA
Pieter Neels
IABS, Switzerland
Carmen Jungbäck
IABS, Switzerland
Luca Benetti
Merck & Co., USA
Johannes Blümel
Paul-Ehrlich-Institut, Germany
Hansi Dean
Takeda Vaccines, USA
Dieter Deforce
Ghent University, Belgium
Ivana Knezevic
World Health Organization, Switzerland
Alan Fauconnier
Federal Agency for Medicines and Health Products, Belgium
Robin Levis,Ph.D.
Laurent Mallet
Sanofi Pasteur, France
Philip Minor
National Institute for Biological Standards and Control, United Kingdom
Gayle Pulle
Health Canada

Meeting management:

Geneva, Switzerland

Objectives of the Workshop

The 2017 NGS conference will discuss current perspectives on NGS for adventitious virus detection in biologics with focus on applications for human vaccines and lessons learnt from veterinary vaccines. The meeting will include data presentations and discussions for developing a scientific consensus to draft points for consideration for using NGS for virus detection in selected applications of biologics. The meeting will bring together representatives from industry, academia, service providers, and regulatory bodies.